Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2008
01/24/2008CA2657776A1 Triazolyl phenyl benzenesulfonamides
01/24/2008CA2657745A1 Pyrimidine derivatives and their use as pesticides
01/24/2008CA2657346A1 Formulations for benzimidazolyl pyridyl ethers
01/24/2008CA2657280A1 Macrocyclic compounds useful as bace inhibitors
01/24/2008CA2657258A1 Amino-piperidine derivatives as cetp inhibitors
01/24/2008CA2656869A1 Macrocyclic lactams
01/24/2008CA2656715A1 Compounds and compositions as itpkb inhibitors
01/24/2008CA2656357A1 Process for making 3-substituted 2-amino-5-halobenzamides
01/23/2008EP1880995A1 Method for producing indole derivative having piperidine ring
01/23/2008EP1880993A1 Nitrogen-containing heterocyclic compound
01/23/2008EP1879887A2 Npy antagonists, preparation and use
01/23/2008EP1879882A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
01/23/2008EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
01/23/2008EP1879878A2 New heterocyclylethylcarboxamide derivatives
01/23/2008EP1879873A1 Neurotherapeutic azole compounds
01/23/2008EP1879581A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
01/23/2008EP1879580A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
01/23/2008EP1879577A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
01/23/2008EP1732898B1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors
01/23/2008EP1711825A4 Conjugated small molecules
01/23/2008EP1673086B1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors
01/23/2008EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
01/23/2008EP1644339B1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
01/23/2008EP1569934B1 Cyclopropyl compounds as ccr5 antagonists
01/23/2008EP1556354B1 Therapeutic piperazine derivates useful for treating pain
01/23/2008EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
01/23/2008EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds
01/23/2008EP1436283B1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
01/23/2008EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
01/23/2008EP1427721B1 Method for synthesis of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione
01/23/2008EP1409479B1 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists
01/23/2008EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
01/23/2008EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
01/23/2008EP1322619B1 Isoquinolinone potassium channel inhibitors
01/23/2008EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
01/23/2008EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3
01/23/2008EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity
01/23/2008EP1137406B2 Transdermal patch for delivering volatile liquid drugs
01/23/2008CN101111492A 吲哚衍生物 Indole derivatives
01/23/2008CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy
01/23/2008CN101111489A Amino-pyridines as inhibitors of beta-secretase
01/23/2008CN101111488A Novel compounds
01/23/2008CN101111479A Pyridones used as inhibitors of kinases
01/23/2008CN101111250A Substituted 5-phenyl pyrimidines i in therapy
01/23/2008CN101108830A Cyclic compound, process for producing the same, and pest control agent
01/23/2008CN101108825A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
01/23/2008CN100363458C White electroluminescent polymer material and its preparing method
01/23/2008CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases
01/22/2008US7321045 Vitronectin receptor antagonist pharmaceuticals
01/22/2008US7321036 Process for preparing aluminum trisquinoline complex
01/22/2008US7320996 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer
01/22/2008US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
01/22/2008US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis
01/22/2008US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
01/22/2008US7320992 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
01/22/2008US7320991 Analogs of thalidomide as potential angiogenesis inhibitors
01/22/2008US7320990 Hygroscopicity and high melting point, naphthalene-1,5-disulfonic acid salt of biphenyl-2-ylcarbamic acid 1-{9-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydro-quinolin-5-yl)ethylamino]nonyl}piperidin-4-yl ester, pulmonary disorder
01/22/2008US7320986 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example
01/22/2008US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1
01/22/2008US7320981 Variolin derivatives as anti-cancer agents
01/22/2008US7320977 Substituted 2-phenyl-3(2h)-pyridazinones
01/22/2008US7320975 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi
01/22/2008CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance
01/22/2008CA2293553C Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase
01/22/2008CA2281721C Phthalazines with angiogenesis inhibiting activity
01/17/2008WO2008008747A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
01/17/2008WO2008008493A2 Alkyne-substituted pyridone compounds and methods of use
01/17/2008WO2008008453A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
01/17/2008WO2008008375A2 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of inflammation
01/17/2008WO2008008059A1 Anti-cancer agents ans uses thereof
01/17/2008WO2008008022A1 Isoindoline derivatives for the treatment of arrhythmias
01/17/2008WO2008008020A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents
01/17/2008WO2008007979A1 (2,6-dioxo-3-piperinyl)amidobenzoic immunomodulatory and anti-cancer derivatives
01/17/2008WO2008007900A1 Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008WO2008007766A1 Crystal of benzoxadiazole derivative
01/17/2008WO2008007123A2 Pharmaceutical compounds
01/17/2008WO2008007081A1 Short-acting benzodiazepine salts and their polymorphic forms
01/17/2008WO2008007071A1 Short-acting benzodiazepine salts and their polymorphic forms
01/17/2008WO2008006875A1 Fungicide hydroximoyl-tetrazole derivatives
01/17/2008WO2008006874A1 Fungicide hydroximoyl-tetrazole derivatives
01/17/2008WO2008006790A1 Indole compounds
01/17/2008WO2008006703A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
01/17/2008WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds
01/17/2008WO2008006663A1 2-arylindole derivatives as npges-i inhibitors
01/17/2008WO2008006627A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents
01/17/2008WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors
01/17/2008WO2008006560A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
01/17/2008WO2008006480A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators
01/17/2008WO2008006479A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors
01/17/2008WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof
01/17/2008WO2007125405A3 Substituted 2-amino-fused heterocyclic compounds
01/17/2008WO2007096777A3 Crystal form of besipirdine chlorhydrate, process preparation and use thereof
01/17/2008WO2007084413B1 Methods for treating hepatitis c
01/17/2008WO2006056930A3 Novel 4 -aminopiperidine derivatives as plasmepsin ii inhibitors
01/17/2008US20080015243 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
01/17/2008US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction
01/17/2008US20080015233 2,4,6-Substituted Pyridyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
01/17/2008US20080015230 Heterocyclic derivatives and their use as therapeutic agents
01/17/2008US20080015225 Dimeric Piperidine Derivatives